Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Attached to antibody or antibody fragment or immunoglobulin;...
Reexamination Certificate
2004-12-06
2009-10-27
Jones, Dameron L (Department: 1618)
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Attached to antibody or antibody fragment or immunoglobulin;...
C424S001110, C424S001810, C424S001290, C530S387100
Reexamination Certificate
active
07608240
ABSTRACT:
The present invention provides a novel approach to cancer therapy and diagnostics that utilizes nanotubes and other similar nanostructures as both an indirect source of radiation therapy (BNCT), and as delivery vehicles for other types of radio- and chemo-therapeutic materials, as well as imaging agents for diagnostic purposes.
REFERENCES:
patent: 5565215 (1996-10-01), Gref et al.
patent: 6165440 (2000-12-01), Esenaliev
Hawthorne et al., “A critical assessment of boron target compounds for boron neutron capture therapy” 62 J. Neuro-Oncology (2003), pp. 33-45.
Chopra et al., “Measurement of the elastic modulus of a multi-wall boron nitride nanotube” 105 Solid State Commun. (1998), pp. 297-300.
Cumings et al., “Mass-production of boron nitride double-wall nanotubes and nanococoons”, 316 Chem. Phys. Lett. (2000), pp. 211-216.
Demczyk et al., “Structure of boron nitride nanotubules”, 78 Appl. Phys. Lett. 18 (2001), pp. 2772-2774.
Mickelson et al., “Packing C60 in boron nitride nanotubes”, 300 Science, (2003), pp. 467-469.
Bahr et al., “Covalent chemistry of single-wall carbon nanotubes” 12 J. Mater. Chem. (2002), pp. 1952-1958.
Immobilized Affinity Ligand Techniques, Hermanson et al., Eds., Academic Press, New York (1992), p. 45.
Liu et al., “Fullurene pipes”, 280 Science (1998), pp. 1253-1256.
Korfmacher et al., “Analysis of 1- and 4-nitropyrene and 1-nitopyrene-d9 via fused siloca . . . ”, 7 J. High Resolut. Chrom. Commun. (1984), pp. 581-583.
Miller et al., “Synthesis of nitropolycyclic aromatic hydrocarbons with the substituent at the longest axis”, 57 J. Org. Chem. (1992), pp. 3746-3748.
Ledingham et al., “Laser-driven photo-transmutation of 129I—a long-lived nuclear waste product” 36 J. Phys. D: Appl. Phys. (2003), pp. L79-L82.
Zhang, et al., “Rapid ring-opening polymerization of D,L-Lactide by microwaves”, 25 Macromol. Rapid Commun. (2004), pp. 1402-1405.
Yanch et al., “Boron neutron capture synovectomy: Treatment of rheumatoid arthritis . . . ”, 26 Med. Phys. 3 (1999), pp. 364-375.
Berger Richard
Biris Alex
Buzatu Dan A.
Darsey Jerry A.
Diggs Mark
Board of Trustees of the University of Arkansas
Jones Dameron L
Winstead PC
LandOfFree
Nanotubes for cancer therapy and diagnostics does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nanotubes for cancer therapy and diagnostics, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nanotubes for cancer therapy and diagnostics will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4084274